Hartmannův Roztok Viaflo

Hartmannův Roztok Viaflo is an intravenous electrolyte solution that combines potassium chloride, sodium chloride, calcium chloride dihydrate, and sodium lactate. Formulated for fluid and electrolyte replenishment, the product is supplied as a sterile solution for intravenous infusion. It is marketed in the European Union and requires a prescription. The formulation is designed to support extracellular fluid volume, electrolyte balance, and acid‑base homeostasis during clinical care.

Hartmannův Roztok Viaflo is indicated for clinical situations where rapid restoration of fluid volume and electrolyte concentrations is required. It is commonly employed in peri‑operative settings, dehydration, and conditions associated with electrolyte loss.

- Replacement of extracellular fluid losses during surgery or trauma. - Treatment of dehydration caused by gastrointestinal fluid loss. - Correction of electrolyte imbalances such as hyponatremia or hypokalemia. - Maintenance of fluid balance in patients receiving parenteral nutrition. - Support of acid‑base equilibrium in metabolic acidosis.

Side effects of Hartmannův Roztok Viaflo are generally related to the electrolyte composition and volume of infusion.

Common: - Mild irritation at the infusion site, such as redness or itching. - Transient increase in serum sodium or potassium levels that resolves without intervention. - Slight elevation of blood pressure due to volume expansion.

Serious: - Hyperkalemia leading to cardiac arrhythmias in susceptible patients. - Severe hypernatremia causing neurological symptoms such as confusion or seizures. - Fluid overload resulting in pulmonary edema or congestive heart failure.

When prescribing Hartmannův Roztok Viaflo, clinicians should evaluate patient-specific factors to minimize risks.

- Assess renal function before administration, especially in patients with impaired clearance. - Monitor serum electrolytes regularly during infusion to detect imbalances. - Use caution in patients with congestive heart failure or pulmonary edema. - Adjust infusion rate in individuals at risk of rapid volume expansion. - Avoid use in patients with known hypersensitivity to any component of the solution. - Consider alternative fluids for neonates and infants unless specifically indicated.

Hartmannův Roztok Viaflo may interact with other medications that affect electrolyte balance or fluid status.

Avoid: - Concurrent administration of potassium‑sparing diuretics that could precipitate hyperkalemia. - High‑dose sodium bicarbonate infusions that may exacerbate sodium overload.

Use with caution: - Loop diuretics, which can cause rapid shifts in potassium and sodium levels. - ACE inhibitors or ARBs, which may alter renal handling of electrolytes. - Blood products containing citrate, as citrate metabolism can influence calcium concentrations.